• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在再灌注早期静脉注射腺苷减轻心肌再灌注损伤。

Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.

作者信息

Pitarys C J, Virmani R, Vildibill H D, Jackson E K, Forman M B

机构信息

Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn.

出版信息

Circulation. 1991 Jan;83(1):237-47. doi: 10.1161/01.cir.83.1.237.

DOI:10.1161/01.cir.83.1.237
PMID:1984882
Abstract

Adenosine influences the function of several cell types thought to be involved in the pathogenesis of myocardial reperfusion injury. We have previously demonstrated that intracoronary administration of adenosine enhances myocardial salvage 24 hours after reperfusion. To determine if these beneficial effects could be obtained during a prolonged period of reperfusion using an intravenous route of administration, 22 closed-chest dogs were subjected to 90 minutes of proximal left anterior descending coronary artery occlusion and 72 hours of reperfusion. Animals randomly received either intravenous adenosine (0.15 mg/kg/min) or an equal volume of Ringer's lactate during the first 150 minutes of reperfusion. The area at risk was defined in vivo with Monastral blue, and infarct size was measured histologically with Mallory's trichrome stain. Serial global and regional ventricular function were determined with contrast ventriculography and analyzed using a computerized radial shortening method. Biopsies were obtained from the central ischemic zone to assess endothelial ultrastructure and capillary obstruction. No significant effects in heart rate or blood pressure were noted during adenosine infusion. Transmural collateral blood flow during ischemia was similar in the groups. Infarct size expressed as a percentage of the anatomical area at risk was significantly less in the adenosine-treated group (35.3 +/- 4.3% in controls versus 17.1 +/- 4.3% in treated animals, p less than 0.01). A progressive decrease in transmural blood flow was noted in control animals during reperfusion, resulting in a significant reduction at 3 hours compared with the preocclusion value (0.69 +/- 0.11 ml/min/g [at baseline versus 0.45 +/- 0.10 ml/min/g at 3 hours, p less than 0.05]). In contrast, flow in adenosine animals at 3 hours was similar to baseline values (0.91 +/- 0.15 ml/min/g at baseline versus 0.98 +/- 0.14 ml/min/g at 3 hours, p = NS) and was significantly higher (p less than 0.05) than the control group. Radial shortening in the ischemic zone was significantly improved at 3 (-2.6 +/- 2.8% in controls versus 11.6 +/- 3.3% in treated animals, p less than 0.01) and 72 hours (5.5 +/- 2.0% in controls versus 17.3 +/- 3.5% in treated animals, p less than 0.01) after reperfusion in treated animals. Electron microscopy showed reduced neutrophil and erythrocyte plugging of capillaries with relative preservation of endothelial cell structure in the adenosine group.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

腺苷会影响几种被认为参与心肌再灌注损伤发病机制的细胞类型的功能。我们之前已经证明,冠状动脉内给予腺苷可在再灌注24小时后增强心肌挽救。为了确定使用静脉给药途径在延长的再灌注期间是否能获得这些有益效果,对22只闭胸犬进行了90分钟的左前降支冠状动脉近端闭塞和72小时的再灌注。在再灌注的前150分钟内,动物随机接受静脉腺苷(0.15mg/kg/分钟)或等体积的乳酸林格液。用莫那斯特蓝在体内确定危险区域,并用马洛里三色染色组织学测量梗死面积。用对比心室造影确定系列全心和局部心室功能,并使用计算机化径向缩短方法进行分析。从中心缺血区获取活检组织以评估内皮超微结构和毛细血管阻塞情况。在输注腺苷期间未观察到对心率或血压有显著影响。两组在缺血期间的透壁侧支血流相似。以危险解剖区域的百分比表示的梗死面积在腺苷治疗组中显著更小(对照组为35.3±4.3%,治疗动物组为17.1±4.3%,p<0.01)。在再灌注期间,对照组动物的透壁血流逐渐减少,与闭塞前值相比,在3小时时显著降低(基线时为0.69±0.11ml/分钟/克,3小时时为0.45±0.10ml/分钟/克,p<0.05)。相比之下,腺苷组动物在3小时时的血流与基线值相似(基线时为0.91±0.15ml/分钟/克,3小时时为0.98±0.14ml/分钟/克,p=无显著性差异),且显著高于对照组(p<0.05)。在治疗动物中,再灌注后3小时(对照组为-2.6±2.8%,治疗动物组为11.6±3.3%,p<0.01)和72小时(对照组为5.5±2.0%,治疗动物组为17.3±3.5%,p<0.01)时,缺血区的径向缩短显著改善。电子显微镜显示,腺苷组毛细血管中的中性粒细胞和红细胞阻塞减少内皮细胞结构相对保留。(摘要截短至400字)

相似文献

1
Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.在再灌注早期静脉注射腺苷减轻心肌再灌注损伤。
Circulation. 1991 Jan;83(1):237-47. doi: 10.1161/01.cir.83.1.237.
2
Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model.在犬模型中,再灌注后冠状动脉内给予腺苷可限制长时间缺血后的血管损伤。
Circulation. 1989 Nov;80(5):1388-99. doi: 10.1161/01.cir.80.5.1388.
3
Intracoronary adenosine administration during reperfusion following 3 hours of ischemia: effects on infarct size, ventricular function, and regional myocardial blood flow.缺血3小时后再灌注期间冠状动脉内给予腺苷:对梗死面积、心室功能及局部心肌血流的影响
Am Heart J. 1990 Oct;120(4):808-18. doi: 10.1016/0002-8703(90)90196-5.
4
Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.比马卡林是一种ATP敏感性钾通道开放剂,可模拟缺血预处理的作用,以缩小犬类的梗死面积、减少腺苷释放并降低中性粒细胞功能。
Circulation. 1995 Sep 1;92(5):1236-45. doi: 10.1161/01.cir.92.5.1236.
5
Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.在犬类再灌注模型中,氟碳化合物对中性粒细胞的药理学干扰导致梗死面积持续减小。
J Am Coll Cardiol. 1992 Jan;19(1):205-16. doi: 10.1016/0735-1097(92)90074-w.
6
Myocardial reperfusion injury in the canine model after 40 minutes of ischemia: effect of intracoronary adenosine.犬缺血40分钟后心肌再灌注损伤:冠状动脉内注射腺苷的作用
Am Heart J. 1991 Dec;122(6):1561-70. doi: 10.1016/0002-8703(91)90272-j.
7
Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.冠状动脉内注射腺苷减轻犬模型的再灌注损伤:内皮及无复流现象的重要性
Circulation. 1987 Nov;76(5):1135-45. doi: 10.1161/01.cir.76.5.1135.
8
Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.通过注射流变学药物RheothRx(泊洛沙姆188美国国家处方集)减少犬再灌注诱导的心肌坏死,该药物可改变中性粒细胞功能。
Circulation. 1994 Dec;90(6):2964-75. doi: 10.1161/01.cir.90.6.2964.
9
Effects of oral pretreatment with metoprolol on left ventricular wall motion, infarct size, hemodynamics, and regional myocardial blood flow in anesthetized dogs during thrombotic coronary artery occlusion and reperfusion.美托洛尔口服预处理对麻醉犬在冠状动脉血栓形成闭塞及再灌注期间左心室壁运动、梗死面积、血流动力学和局部心肌血流量的影响。
Cardiovasc Drugs Ther. 1994 Jun;8(3):479-87. doi: 10.1007/BF00877926.
10
Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow.静脉注射腺苷对低心肌侧支血流模型中心肌再灌注损伤的影响。
Am Heart J. 1991 Nov;122(5):1283-91. doi: 10.1016/0002-8703(91)90567-2.

引用本文的文献

1
Adenosine-Induced Coronary Steal Is Observed in Patients Presenting With ST-Segment-Elevation Myocardial Infarction.腺苷诱导的冠状动脉窃血现象见于 ST 段抬高型心肌梗死患者。
J Am Heart Assoc. 2021 Jul 6;10(13):e019899. doi: 10.1161/JAHA.120.019899. Epub 2021 Jun 30.
2
Schisandra chinensis bee pollen's chemical profiles and protective effect against HO-induced apoptosis in H9c2 cardiomyocytes.北五味子蜂花粉的化学成分及其对 H9c2 心肌细胞氧化损伤诱导的细胞凋亡的保护作用。
BMC Complement Med Ther. 2020 Sep 10;20(1):274. doi: 10.1186/s12906-020-03069-1.
3
Alda‑1, an aldehyde dehydrogenase‑2 agonist, improves long‑term survival in rats with chronic heart failure following myocardial infarction.
Alda-1,一种乙醛脱氢酶-2 激动剂,可改善心肌梗死后慢性心力衰竭大鼠的长期存活率。
Mol Med Rep. 2018 Sep;18(3):3159-3166. doi: 10.3892/mmr.2018.9309. Epub 2018 Jul 24.
4
Adenosine Receptor-Mediated Cardioprotection-Current Limitations and Future Directions.腺苷受体介导的心脏保护作用——当前局限与未来方向
Front Pharmacol. 2018 Apr 4;9:310. doi: 10.3389/fphar.2018.00310. eCollection 2018.
5
Protective effects of GV1001 on myocardial ischemia‑reperfusion injury.GV1001 对心肌缺血再灌注损伤的保护作用。
Mol Med Rep. 2017 Nov;16(5):7315-7320. doi: 10.3892/mmr.2017.7528. Epub 2017 Sep 19.
6
Optimal Duration of Coronary Ligation and Reperfusion for Reperfusion Injury Study in a Rat Model.大鼠模型中再灌注损伤研究的冠状动脉结扎和再灌注最佳持续时间
Acta Cardiol Sin. 2016 Jul;32(4):491-7. doi: 10.6515/acs20150824b.
7
Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatment.急性心肌梗死中的细胞死亡机制:对治疗的病理生理学意义
Neth Heart J. 2001 Apr;9(1):30-44.
8
Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future.预处理和后处理中的信号通路与保护机制:历史视角及对未来的启示
Br J Pharmacol. 2015 Apr;172(8):1913-32. doi: 10.1111/bph.12903. Epub 2014 Nov 24.
9
Cardioprotection and myocardial reperfusion: pitfalls to clinical application.心肌保护和心肌再灌注:临床应用的陷阱。
Circ Res. 2013 Aug 2;113(4):464-77. doi: 10.1161/CIRCRESAHA.113.300765.
10
Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.线粒体作为缺血性心脏病和心肌病的药物靶点。
Circ Res. 2012 Oct 12;111(9):1222-36. doi: 10.1161/CIRCRESAHA.112.265660.